Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

Dr Alexander (Sandy) Douglas in a medical research laboratory

Dr Sandy Douglas was awarded a 5 year Wellcome Stage 2 Clinical Research Career Development Fellowship, receiving £1.3m of funding to investigate development of new vaccines against rabies and Epstein Barr virus. On the back of his strong fellowship application, he also was one of four recipients of a Wellcome-Beit prize, worth another £25k of funding. This prize is awarded annually to Wellcome’s strongest applicants across their range of intermediate-level clinical & non-clinical fellowship schemes.

Dr Sandy Douglas commented upon receiving the news: “I’m really grateful to Wellcome for the opportunity to start work on vaccines against Epstein Barr virus. As well as glandular fever the virus causes many cancers and seems to be a prerequisite for development of multiple sclerosis, but it’s a tricky target and has been quite neglected by vaccine developers. The Jenner & the wider NDM are the perfect setting to enable progress in this important area.”

Similar stories

Communication at the crossroads of the immune system

In his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team in Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.

Showcase success for Science Together research

A local collaboration teaming researchers from the University of Oxford and Oxford Brookes University with the Urban Music Foundation finished on a high note with an immersive sound and art installation at Oxford’s Old Fire Station.

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.